| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UROLOGY.2005.01.060 |
| P8608 | Fatcat ID | release_yvr2cangfbfcnmpfidxigpxh54 |
| P698 | PubMed publication ID | 15992911 |
| P50 | author | Elizabeth A Platz | Q89968613 |
| Martha K Terris | Q37369787 | ||
| P2093 | author name string | Joseph C Presti | |
| Stephen J Freedland | |||
| P2860 | cites work | Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers | Q40900660 |
| Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group | Q42616120 | ||
| The association of body mass index and prostate-specific antigen in a population-based study | Q44009101 | ||
| Body mass index and risk of prostate cancer in U.S. health professionals | Q44555971 | ||
| Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada | Q47353839 | ||
| Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia | Q47938396 | ||
| Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. | Q50671556 | ||
| Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. | Q54229593 | ||
| Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia | Q67679170 | ||
| Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer | Q73182302 | ||
| Prevalence and Trends in Obesity Among US Adults, 1999-2000 | Q22253005 | ||
| Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. | Q30982763 | ||
| Dietary fat and prostate cancer: current status | Q33539814 | ||
| Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy | Q34285704 | ||
| Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. | Q34327135 | ||
| Hormones and prostate cancer: current perspectives and future directions | Q34732880 | ||
| The underlying basis for obesity: relationship to cancer | Q34992018 | ||
| Energy imbalance and prostate cancer | Q34992029 | ||
| Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review | Q35032572 | ||
| Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. | Q35772598 | ||
| Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. | Q36671178 | ||
| Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). | Q39509015 | ||
| Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network | Q39545483 | ||
| Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population | Q39684065 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biopsy | Q179991 |
| prostate cancer | Q181257 | ||
| P304 | page(s) | 108-113 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Body mass index as a predictor of prostate cancer: development versus detection on biopsy | |
| P478 | volume | 66 |
| Q39999255 | Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study |
| Q36189752 | Advantages of robot-assisted laparoscopic radical prostatectomy in obese patients: comparison with the open procedure |
| Q44443320 | Analysis of the anatomical characteristics of the pelvis in Koreans to aid in development of a NOTES platform |
| Q34621809 | Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study |
| Q44403298 | Body mass index and prognostic markers at radical prostatectomy |
| Q36791463 | Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy? |
| Q40077148 | Body mass index influences prostate cancer risk at biopsy in Japanese men. |
| Q46853658 | Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study |
| Q36569170 | Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model |
| Q37361333 | Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. |
| Q43959465 | Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes |
| Q37705539 | Efficacy of Repeated Transrectal Prostate Biopsy in Men Younger Than 50 Years With an Elevated Prostate-Specific Antigen Concentration (>3.0 ng/mL): Risks and Benefits Based on Biopsy Results and Follow-up Status |
| Q98891908 | External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study |
| Q34453379 | Handling difficult anastomosis. Tips and tricks in obese patients and narrow pelvis |
| Q37245092 | Health risk behaviors and prostate specific antigen awareness among men in California |
| Q39938973 | Higher body mass index is associated with lower risk of prostate cancer detection via multi (≥ 12)-core prostate biopsy in Korean men. |
| Q24604996 | Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy |
| Q45231858 | Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancer |
| Q37819422 | Influence of obesity on the incidence and treatment of genitourinary malignancies |
| Q44871735 | Is Body Mass Index the Best Adiposity Measure for Prostate Cancer Risk? Results From a Veterans Affairs Biopsy Cohort |
| Q38871813 | Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk |
| Q40957387 | Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease. |
| Q84185768 | Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database |
| Q62524889 | Obesity Is Not Associated With Aggressive Pathologic Features or Biochemical Recurrence After Radical Prostatectomy |
| Q36968554 | Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate |
| Q84961250 | Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate |
| Q34641998 | Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study |
| Q35231117 | Obesity is a significant risk factor for prostate cancer at the time of biopsy |
| Q40155962 | Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea |
| Q39929949 | Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels |
| Q40271605 | Prostate cancer detection: The impact of obesity on Asian men. |
| Q36284738 | Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy |
| Q50733820 | Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution. |
| Q39858236 | The association between metabolic syndrome and prostate-specific antigen levels |
| Q37926897 | The association of diabetes and positive prostate biopsy in a US veteran population |
| Q34072520 | The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes |
| Q38316336 | Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR? |
| Q37910709 | Urological aspects of the metabolic syndrome |
| Q45964128 | [Advances on the influence of adipose tissue on prostate cancer]. |
| Q94891334 | [Obesity and prostatic cancer] |
Search more.